If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
244.00    -2.00 (-0.83%)
Bid:
231.00
Ask:
245.00
Spread: 14.00 (6.061%)
Market Cap: £78.05m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

20 Apr 2026 16:32

RNS Number : 1867B
Braemar PLC
20 April 2026
 

 

20 April 2026

BRAEMAR PLC

("Braemar" the "Company")

 

PDMR Share Dealing

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that on 17 April 2026, James Gundy, Group Chief Executive Officer, exercised 218,750 nil cost options ("Options") granted under the Company's Long Term Incentive Plan ("LTIP") as set out below:

 

LTIP award grant date

 

Vesting date

Two-year holding period end date

 

Number of Options exercised

24 July 2020

24 July 2023

24 July 2025

218,750

 

 

The 2020 LTIP award vested following the assessment of the applicable performance conditions which were disclosed in the 2023 remuneration report (page 83), this report is available on the Company's website at Financial Reports - Braemar.

 

The exercise of the Options under the LTIP, has been satisfied through the allocation of existing ordinary shares held by the Braemar Employee Share Ownership Plan; as such, no new ordinary shares have been issued. In order to cover tax and national insurance liabilities arising from the exercise of the Options, James Gundy sold 103,088 shares on 17 April 2026 and retained the balance of 115,662 shares.

Following the above transactions, James Gundy's total shareholding is now 1,139,695 (being 3.4% of the Company's issued share capital).

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, contact:

 

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial & Operating Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Polly Clarke

Tel: +44 (0)77 3303 2695

braemar@houston.co.uk

Canaccord Genuity

Tel: +44 (0) 20 7523 8000

Adam James / Harry Rees

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

 

Reason for the notification

Position/status

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2020

Price(s) and volume(s)

Price: £0.00

 

Volume: 218,750

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 218,750

Date of the transaction

17 April 2026

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Sale of shares to cover tax and national insurance following exercise of Options granted under the Company's LTIP in 2020

 

Price(s) and volume(s)

Price: £2.202792

 

Volume: 103,088

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £227,081.42

 

Volume: 103,088

Date of the transaction

17 April 2026

 

Place of the transaction 

London Stock Exchange (XLON)

 

 

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice to the shipping and energy markets that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGZDKGGGVZM
Date   Source Headline
16th Jun 20207:00 amRNSPreliminary Results
2nd Jun 20207:00 amRNSNotice of Preliminary Results
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20201:24 pmRNSDisclosure of rights attached to equity shares
23rd Apr 20207:00 amRNSBusiness Update
31st Mar 20207:00 amRNSTotal Voting Rights
3rd Mar 20207:00 amRNSPre-Close Trading Update
14th Feb 20207:00 amRNSBlock listing six monthly return
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20208:54 amRNSDirector / PDMR Shareholding
31st Dec 20197:00 amRNSTotal Voting Rights
12th Nov 201910:26 amRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights
24th Oct 20197:00 amRNSInterim Results
9th Oct 20197:00 amRNSChange of Corporate Broker & Notice of Results
27th Sep 20192:30 pmRNSDirector Declaration
30th Aug 20192:53 pmRNSTotal Voting Rights
30th Aug 201911:15 amRNSDirector/PDMR Shareholding
21st Aug 20197:00 amRNSDirector/PDMR Shareholding
19th Aug 20197:00 amRNSRebranding of Engineering Division
16th Aug 20197:00 amRNSBlock Listing Application
6th Aug 20197:00 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSBoard Changes
16th Jul 20191:59 pmRNSHolding(s) in Company
8th Jul 20196:04 pmRNSEmployee Share Scheme & Director/PDMR Shareholding
8th Jul 20193:40 pmRNSHolding(s) in Company
4th Jul 20194:31 pmRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSResults of Annual General Meeting
3rd Jul 20197:00 amRNSAGM Trading Update
21st Jun 201911:46 amRNSCompletion of Combination of Braemar Technical
20th Jun 20194:53 pmRNSDirector/PDMR Shareholding
18th Jun 20192:25 pmRNSHolding(s) in Company
11th Jun 20192:00 pmRNSResult of Aqualis ASA AGM
7th Jun 20195:16 pmRNSAnnual Report and Notice of General Meeting
20th May 20197:00 amRNSPreliminary Results
13th May 20197:00 amRNSProposed Combination of Braemar Technical Services
15th Apr 20197:00 amRNSAppointment of Non-Executive Chairman
25th Mar 20197:00 amRNSPre-Close Trading Update and Notice of Results
1st Mar 20194:38 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSDirectorate Changes
25th Jan 20197:00 amRNSTrading Update
13th Dec 20187:00 amRNSAppointment of Finance Director
22nd Nov 20187:00 amRNSChange of Auditor
5th Nov 201810:15 amRNSDirector / PDMR Shareholding
25th Oct 20187:00 amRNSInterim Results
12th Oct 201811:08 amRNSESOP Trading Plan
10th Oct 20187:00 amRNSDisposal of Braemar Response
3rd Oct 20187:00 amRNSBoard Change
5th Sep 20189:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.